Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

It took seven years for Madeline Shonka to be diagnosed with lupus. Unfortunately, her struggles didn’t end there.  The side effects of medications for lupus that her healthcare providers prescribed were often debilitating side effects, such as weight gain, rashes and even difficulty managing anger. Then, over time, her physicians tested different, better-suited treatments on Shonka. She found that certain new habits, like light exercise, made a big difference in her quality of life. She then founded Co-immunity, which hosts support groups for patients with chronic illnesses, so that they can share their experiences. What Is Lupus? Lupus is an…

Read More

​Early in Dee Mangin’s career as a primary-care physician, she noticed that many people, especially older adults, were prescribed large numbers and doses of drugs, which, in some cases, might actually be detracting from their health rather than improving it. Then, she realized that even when polypharmacy (being prescribed five or more medications simultaneously) was recognized as a problem, there wasn’t any systematic way to help patients and healthcare providers assess which medicines might be most effective in a lower dose or discontinued altogether.  Mangin is an MBChB (the New Zealand equivalent of an MD) and DPH (doctor of public…

Read More